A novel ansamycin, rifamycin W, was isolated from a mutant strain of Nocardia mediterranei. The metabolic origin of rifamycin W was studied by 13C nuclear magnetic resonance spectroscopy. Examination of the proton-decoupled pulse and Fourier transform 13C spectra of rifamycin W biogenetically enriched with [1-13C1-, [1-'3C~acetate has revealed that In a previous publication (9) describing the biosynthesis of rifamycin S, we proposed a general scheme for the biogenesis of the ansamycin carbon skeleton in which a single polyketide chain is initiated by a seven carbon amino precursor containing a six-membered ring. According to this scheme, the naphthalenic chromophore, when present, is formed by closure of a second ring including the 2nd, 3rd, and 4th carbons of the polyketide chain, e.g., C-7, C-6, and C-5 in the case of the rifamycins. The results obtained with rifamycin S (9) also implied that a common progenitor might be involved in the formation of the different naphthalenic ansamycins. 
The rifamycins are a family of closely related antibiotics first isolated from the fermentation medium of Nocardia mediterranei at the Lepetit Laboratories in 1957 (1, 2) . They were the first examples of a novel class of secondary metabolites characterized by the possession of an aliphatic ansa chain bridging an aromatic chromophore, which Prelog has denominated the ansamycins (3) . Members of this group so far identified can be divided into two subgroups according to the chromophore present: those containing a naphthalenic moiety [rifamycins, tolypomycins (4) , and streptovaricins (5) ] and those containing a benzenic moiety [maytansines (6) , colubrinol (7) , and geldanamycin (8) ]; representative structures are shown in Scheme 1. In a previous publication (9) describing the biosynthesis of rifamycin S, we proposed a general scheme for the biogenesis of the ansamycin carbon skeleton in which a single polyketide chain is initiated by a seven carbon amino precursor containing a six-membered ring. According to this scheme, the naphthalenic chromophore, when present, is formed by closure of a second ring including the 2nd, 3rd, and 4th carbons of the polyketide chain, e.g., C-7, C-6, and C-5 in the case of the rifamycins. The results obtained with rifamycin S (9) also implied that a common progenitor might be involved in the formation of the different naphthalenic ansamycins. This precursor would have fundamentally the same carbon skeleton as the streptovaricins, and would give rise to the rifamycins by loss of a l)ropionate-derived methyl from the ansa chain and introduction of an ether linkage between the ansa and chromophore. This proposal has promptly received support from the results of [1-'3C ] propionate incorporation into streptovaricin D (10) that indicated a biosynthetic scheme for this compound identical to that independently proposed on the basis of the results obtained for rifamycin S (9) .
During our screening program of N. mediterranei mutants as a source of new natural rifamycins, we have isolated a morphological variant that produced a mixture of novel rifamycins. In the present communication we describe the isolation of the major component, rifamycin W, from the fermentation broth of this mutant and report its biosynthesis and relationship to the normal fermentation product, rifamycin B. Evidence for the structure of this compound will be reported elsewhere (11) . The present results fully support our proposals concerning the biosynthesis of rifamycin S and are consistent with the existence of a common progenitor of the naphthalenic ansamycins. (Fig. 2) . The rifamycin B synthesized was labeled, as shown by the coincidence of the peaks for radioactivity and absorption. Incorporation of 13C-Enriclhed Precursors. The l)rotondecoupled natural abundance '3C nuclear magnetic resonance (NMR) spectrum of rifamycin W in dimethyl sulfoxide is shown in Fig. 3A ; assignment of the resonances will be discussed in a separate publication (11) . Also given in Fig. 3 are the '3C NMR spectra of rifamycin W obtained from fermentations to which [1-13C] propionate, [ Clearly, several mechanisms are possible for the introduction of an oxygen between C-29 and C-12; for example, epoxidation of the double bond C-29, C-12 and subsequent scission of the carbon-carbon. bond, or a modified Baeyer-Villiger Men oxidation may be involved. Acetylation and methylation of the hydroxyls at C-25 and C-27 must be late events in biosynthesis, as judged by the unsubstituted ansa chain of rifamycin W, in agreement with 0 ppm the prior isolation of mutant blocked in methylation that accumulated 27-desmethyl rifamycin SV; 27-desmethyl, 25-desacetyl rifamycin SV; and 27-desmethyl rifamycin B (19) . Prelog et al. (20) have recently pointed out a striking similarity in the stereochemistry of the aliphatic chain of ansamycins and the macrolide model proposed by Celmer (21) . One can safely predict that C-28, which bears the extra carWeSi bon (C34a), has the same chirality as that established for the analogous carbon of the streptovaricins, but verification of this must await x-ray crystallographic studies. We thank Dr. P. Beynon of JEOL Ltd. (U.K.) for recording the 13C-NMR spectra, G. Sartori for expert technical assistance, and Prof. P. Sensi and Prof. G. G. Gallo for advice and encouragement.
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